153 related articles for article (PubMed ID: 9562828)
1. Angiotensin II receptor blockers in hypertension and renal disease.
Bakris GL
Hosp Pract (1995); 1998 Apr; 33(4):19-22. PubMed ID: 9562828
[No Abstract] [Full Text] [Related]
2. Prospective trials of angiotensin receptor blockers: beyond blood pressure control.
Siragy HM; Carey RM
Curr Hypertens Rep; 2000 Apr; 2(2):163-4. PubMed ID: 10981143
[No Abstract] [Full Text] [Related]
3. Cardiology patient page. Angiotensin receptor blockers.
Terra SG
Circulation; 2003 Jun; 107(24):e215-6. PubMed ID: 12821593
[No Abstract] [Full Text] [Related]
4. AT1-receptor blockers.
Petkun W
Eur Heart J; 2000 Feb; 21(4):335-7. PubMed ID: 10653684
[No Abstract] [Full Text] [Related]
5. Angiotensin receptor blockers -- finally the evidence is coming in: IDNT and RENAAL.
Coats AJ
Int J Cardiol; 2001 Jul; 79(2-3):99-102. PubMed ID: 11461726
[No Abstract] [Full Text] [Related]
6. [Efficacy-safety relationship of AT1 angiotensin II receptor antagonists: current data].
Paoletti V; Di Veroli C; Pugliese M; Cammarella I; Cavina G; Turchetti P; Mammarella A
Clin Ter; 2002; 153(1):61-4. PubMed ID: 11963637
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension.
Hedner T; Oparil S; Rasmussen K; Rapelli A; Gatlin M; Kobi P; Sullivan J; Oddou-Stock P
Am J Hypertens; 1999 Apr; 12(4 Pt 1):414-7. PubMed ID: 10232502
[TBL] [Abstract][Full Text] [Related]
8. [Fast-acting sartan. High blood pressure therapy without long waiting time].
MMW Fortschr Med; 2003 Jun; 145(24):55. PubMed ID: 12866306
[No Abstract] [Full Text] [Related]
9. [Lowering blood pressure with sartans. Are there differences?].
MMW Fortschr Med; 2002 Nov; 144(47):63. PubMed ID: 12532530
[No Abstract] [Full Text] [Related]
10. Valsartan treatment of hypertension--does VALUE add value?
Lindholm LH
Lancet; 2004 Jun; 363(9426):2010-1. PubMed ID: 15207946
[No Abstract] [Full Text] [Related]
11. Treatment with the angiotensin II antagonist valsartan in patients with chronic renal failure and hypertension.
Plum J; Bünten B; Németh R; Grabensee B
Nephrol Dial Transplant; 1999; 14 Suppl 4():25-7. PubMed ID: 10463202
[No Abstract] [Full Text] [Related]
12. Fetal toxic effects and angiotensin-II-receptor antagonists.
Martinovic J; Benachi A; Laurent N; Daikha-Dahmane F; Gubler MC
Lancet; 2001 Jul; 358(9277):241-2. PubMed ID: 11480433
[No Abstract] [Full Text] [Related]
13. Examining the association of olmesartan and other angiotensin receptor blockers with overall and cause-specific mortality.
Lin JW; Chang CH; Caffrey JL; Wu LC; Lai MS
Hypertension; 2014 May; 63(5):968-76. PubMed ID: 24516110
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin receptor blockers and aldosterone antagonists in chronic heart failure.
Miller AB; Srivastava P
Cardiol Clin; 2001 May; 19(2):195-202, v. PubMed ID: 11407105
[TBL] [Abstract][Full Text] [Related]
15. [spACE, the last frontier? Renin inhibition in hypertension].
Villa L
G Ital Nefrol; 2008; 25(3):274. PubMed ID: 18473295
[No Abstract] [Full Text] [Related]
16. Sartans for hypertension--implications of the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial.
Cheung BM
Hong Kong Med J; 2004 Oct; 10(5):359. PubMed ID: 15479968
[No Abstract] [Full Text] [Related]
17. Angiotensin type 1 receptor blockers in chronic kidney disease.
Suzuki H
Contrib Nephrol; 2004; 143():159-66. PubMed ID: 15248363
[No Abstract] [Full Text] [Related]
18. Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trial.
Elliott WJ; Calhoun DA; DeLucca PT; Gazdick LP; Kerns DE; Zeldin RK
Clin Ther; 2001 Aug; 23(8):1166-79. PubMed ID: 11558856
[TBL] [Abstract][Full Text] [Related]
19. Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan.
Smith DH; Dubiel R; Jones M
Am J Cardiovasc Drugs; 2005; 5(1):41-50. PubMed ID: 15631537
[TBL] [Abstract][Full Text] [Related]
20. Palatability of angiotensin II antagonists among nephropathic children.
Meier CM; Simonetti GD; Ghiglia S; Fossali E; Salice P; Limoni C; Bianchetti MG;
Br J Clin Pharmacol; 2007 May; 63(5):628-31. PubMed ID: 17302913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]